← Back to Clinical Trials
Recruiting NCT06430476

EMI Therapy for Depression in Hong Kong

Trial Parameters

Condition Mild to Moderate Depression
Sponsor The University of Hong Kong
Study Type INTERVENTIONAL
Phase N/A
Enrollment 80
Sex ALL
Min Age 16 Years
Max Age 65 Years
Start Date 2024-06-30
Completion 2025-08-31
Interventions
EMIEMA

Brief Summary

To determine if a two-week ecological momentary intervention (two EMA + one EMI daily) as augmentation to treatment as usual would reduce depressive symptoms, rumination levels, and functioning in subjects with mild to moderate depression, as compared to active controls receiving three EMA prompts daily.

Eligibility Criteria

Inclusion Criteria: * Aged 16-65 years * Cantonese-speaking ethnic Chinese * Diagnosis of major depressive episode (MDE) established by the Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorder 5th Edition (DSM-V) * 17-item Hamilton Depression Rating Scale (HDRS) ≥ 14 at screening and at baseline (i.e. moderate to severe depression) * Having a smartphone with Internet access and iOS or Android operating system. Exclusion Criteria: * Patients who could not read Chinese, are unable to provide informed consents * Comorbid with other Axis I diagnoses (especially schizoaffective disorder) * With an unstable medical condition or current substance abuse * Have a score of ≥4 on any one of the three items on Positive and Negative Syndrome Scale (P1 Delusion, P2 Conceptual disorganization, P3 Hallucination) * Marked risk of self-harm or suicide that could not be safely managed in an outpatient clinic setting * Currently receiving any other weekly psychosocial the

Related Trials